SAFETY AND IMMUNOLOGIC EFFICACY OF COMBINED IMMUNIZATION IN CHILDREN AGED 6—7 YEARS WITH VACCINES FROM THE NATIONAL CALENDAR OF PROPHYLACTICS VACCINES
https://doi.org/10.22627/2072-8107-2013-12-1-14-17
Abstract
We estimated the safety of the vaccination for prevention of influenza with Grippol® plus vaccine alongside with vaccination with combined preparations for the prevention of diphtheria and tetanus (Td) and measles, rubella, mumps in children aged 6—7 years. We determined that combined immunization with the indicated vaccines proves good tolerability and low reactogenicity. Vaccine Grippol® Plus shows low reactogenicity , high immunologenicity and does not cause cross-suppression of antibodies in co-administration with other vaccines on vaccination calendar. Also concomitant vaccination with Grippol® plus and other vaccines does not inhibit the development of a specific immune response against influenza.
About the Authors
I. V. Konovalov
Russian National Research Medical University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
O. V. Shamsheva
Russian National Research Medical University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
G. A. Elshina
Russian National Research Medical University named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
References
1. Fadel S., Sarazotti M. Cellular immune response in neonates // Int. Rev. Immunol. — 2000; 19 : 173—193.
2. Siergrist C.A. Neonatal and early life vaccinology // Vaccine. — 2001; 19 : 3331—3346.
3. Clark A., Rudd P. Neonatal BCG immunization // Arch. Dis.Child. — 1992; 67 : 473—474.
4. Efficacy of BCG vaccine in the prevention of tuberculosis: metaanalysis of published literature / G.A. Colditz et al. // JAMA. — 1994; 271 : 698—702.
5. Plotkin S.A., Orenstein W.A. Vaccines. — 3rd edition Philadelphia, PA: WB Saunders Co; 1999.
6. A high degree of natural immunogenic priming to the capsular polysaccharide may not prevent Haemophillus influenzae type b meningitis / Anderson P., Ingram D.L, Pichichero M., Peter G. // Pediatr. Infect. Dis. J. — 2000; 19 : 589—591.
7. Abbas A.K., Lichtman A.H., Pober J.S. Cellular and molecular immunology. — 2nd edition. Philadelphia, PA: WB Sauders Co; 1994.
8. Apparent decreased risk of invasive disease after heterologous childhood immunization / S.B. Black et. аl. // Am. J. Dis. Child. — 1991; 145 : 746—749.
9. Addressing Parents’ Concerns: Do multiple vaccines overhelm or weaken the infants’ immune system ?/ А. Paul et al. // Pediatrics. — 2012; 109(1) : 124—129.
10. DTP immunization and susceptibility to infection diseases. Is there a relationship? / М. Davidson et al. // Am. J. Dis. Child. — 1991; 145 : 750—754.
11. General non-specific morbidity is reduced after vaccination within the third month of life — the Greifswal study / S. Otto et al. // J. Infect. — 2000; 41 : 172—175.
12. Опыт сочетанного применения вакцин против менингококковой инфекции и гриппа в эпидситуации / М.П. Костинов и др. // Вакцинация. Новости вакцинопрофилактики. — 2004, № 1 (31). — С. 7—9.
13. Инструкция по применению «Гриппол® Плюс» вакцины гриппозной тривалентной инактивированной полимер-субъединичной утверждена 15.07.2008 г.
Review
For citations:
Konovalov I.V., Shamsheva O.V., Elshina G.A. SAFETY AND IMMUNOLOGIC EFFICACY OF COMBINED IMMUNIZATION IN CHILDREN AGED 6—7 YEARS WITH VACCINES FROM THE NATIONAL CALENDAR OF PROPHYLACTICS VACCINES. CHILDREN INFECTIONS. 2013;12(1):14-17. (In Russ.) https://doi.org/10.22627/2072-8107-2013-12-1-14-17
Views:
812
Email this article 